Potential role of S100A4 in an immune response of rheumatoid arthritis. (22nd February 2011)

• Record Type: Journal Article
• Authors: Andrés Cerezo, Lucie; Kuklová, Markéta; Grigorian, Mariam; Neidhart, Michel; Gay, Steffen; Vencovský, Jiří; Šenolt, Ladislav
• Is Part Of: Annals of the rheumatic diseases. Volume 70(2011)Supplement 2
• Page Start: A85
• Page End: A85
• Publication Date: 2011-02-22
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/ard.2010.149021.9
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: Rheumatoid arthritis (RA) is characterised by systemic and local inflammation caused by enhanced activity of immune cells producing several inflammatory mediators. S100A4 is a protein with metastasis-promoting functions that is significantly upregulated in RA, induces expression of matrix degrading enzymes and regulates apoptosis of synovial fibroblasts. Therefore, the aim of the present study was to investigate the role of S100A4 in an immune response. Methods: Peripheral blood mononuclear cells (PBMC) were isolated from patients with RA. CD14 and CD3 cells were selected from PBMC using microbeads. To investigate extracellular functions, S100A4, S100A8 and S100A12 proteins (1 μg/ml) were used for in vitro experiments. The protein levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1 and IL-6 were assessed using ELISA. Receptor involvement was investigated using antibodies against RAGE, Toll-like receptor (TLR)-4, TLR-2 and inhibitor of MyD88. To determine intracellular signalling pathways, inhibitors of NFκB, p38, ERK1/ERK2 and JNK were used. Results: S100A4 significantly upregulated expression and production of TNFα, IL-1 and IL-6 in PBMC compared to unstimulated cells (p<0.001). Importantly, production of these cytokines was markedly enhanced in response to S100A4 compared to S100A8 or S100A9. In addition, S100A4 upregulated TNFα, IL-1 and IL-6 in both CD14 and CD3 cells (p<0.005). Furthermore, S100A4 induced secretion of these cytokines was significantly blocked by NFκB inhibitor (p<0.01), MyD88 inhibitor (p<0.02) and antibody against TLR-4 (p<0.02), but not by antibodies against RAGE or TLR-2. Blockade of MAP-kinase p38 inhibited most significantly synthesis of TNF-α. Conclusion: This is the first study to demonstrate S100A4 as a potent proinflammatory mediator involved in an immune response. Here the authors show that S100A4 induces production of TNF-α, IL-1 and IL-6 in PBMC via TLR-4 and NFκB dependent pathway and thus may contribute to the pathogenesis of RA.